S&P 500   2,612.90 (+2.81%)
DOW   22,170.20 (+2.47%)
QQQ   191.31 (+3.24%)
AAPL   253.53 (+2.34%)
FB   164.88 (+5.16%)
MSFT   160.13 (+6.97%)
GOOGL   1,143.12 (+2.96%)
AMZN   1,951.96 (+2.73%)
NVDA   263.94 (+4.44%)
BABA   189.72 (+0.60%)
MU   44.29 (+2.22%)
GE   7.88 (+3.28%)
TSLA   505.84 (-1.66%)
AMD   47.92 (+2.88%)
T   30.04 (+0.67%)
ACB   0.88 (-14.52%)
F   5.03 (-3.27%)
NFLX   372.76 (+4.38%)
BAC   22.14 (+2.50%)
GILD   75.60 (+3.77%)
DIS   97.58 (+1.21%)
S&P 500   2,612.90 (+2.81%)
DOW   22,170.20 (+2.47%)
QQQ   191.31 (+3.24%)
AAPL   253.53 (+2.34%)
FB   164.88 (+5.16%)
MSFT   160.13 (+6.97%)
GOOGL   1,143.12 (+2.96%)
AMZN   1,951.96 (+2.73%)
NVDA   263.94 (+4.44%)
BABA   189.72 (+0.60%)
MU   44.29 (+2.22%)
GE   7.88 (+3.28%)
TSLA   505.84 (-1.66%)
AMD   47.92 (+2.88%)
T   30.04 (+0.67%)
ACB   0.88 (-14.52%)
F   5.03 (-3.27%)
NFLX   372.76 (+4.38%)
BAC   22.14 (+2.50%)
GILD   75.60 (+3.77%)
DIS   97.58 (+1.21%)
S&P 500   2,612.90 (+2.81%)
DOW   22,170.20 (+2.47%)
QQQ   191.31 (+3.24%)
AAPL   253.53 (+2.34%)
FB   164.88 (+5.16%)
MSFT   160.13 (+6.97%)
GOOGL   1,143.12 (+2.96%)
AMZN   1,951.96 (+2.73%)
NVDA   263.94 (+4.44%)
BABA   189.72 (+0.60%)
MU   44.29 (+2.22%)
GE   7.88 (+3.28%)
TSLA   505.84 (-1.66%)
AMD   47.92 (+2.88%)
T   30.04 (+0.67%)
ACB   0.88 (-14.52%)
F   5.03 (-3.27%)
NFLX   372.76 (+4.38%)
BAC   22.14 (+2.50%)
GILD   75.60 (+3.77%)
DIS   97.58 (+1.21%)
S&P 500   2,612.90 (+2.81%)
DOW   22,170.20 (+2.47%)
QQQ   191.31 (+3.24%)
AAPL   253.53 (+2.34%)
FB   164.88 (+5.16%)
MSFT   160.13 (+6.97%)
GOOGL   1,143.12 (+2.96%)
AMZN   1,951.96 (+2.73%)
NVDA   263.94 (+4.44%)
BABA   189.72 (+0.60%)
MU   44.29 (+2.22%)
GE   7.88 (+3.28%)
TSLA   505.84 (-1.66%)
AMD   47.92 (+2.88%)
T   30.04 (+0.67%)
ACB   0.88 (-14.52%)
F   5.03 (-3.27%)
NFLX   372.76 (+4.38%)
BAC   22.14 (+2.50%)
GILD   75.60 (+3.77%)
DIS   97.58 (+1.21%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Kiniksa PharmaceuticalsRocket PharmaceuticalsOdonate TherapeuticsAthenexOpko Health
SymbolNASDAQ:KNSANASDAQ:RCKTNASDAQ:ODTNASDAQ:ATNXNASDAQ:OPK
Price Information
Current Price$11.99$13.64$26.92$7.95$1.35
52 Week RangeBuyBuyHoldBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyBuy
Consensus Price Target$25.67$38.67$26.00$25.80$3.17
% Upside from Price Target114.07% upside183.48% upside-3.42% downside224.73% upside135.44% upside
Trade Information
Market Cap$697.58 million$751.71 million$832.04 million$631.82 million$937.76 million
Beta-1.332.641.510.211.98
Average Volume267,124559,38995,164994,66831,502,950
Sales & Book Value
Annual RevenueN/AN/AN/A$101.23 million$901.90 million
Price / SalesN/AN/AN/A6.411.00
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$4.10 per share$6.10 per share$5.06 per share$2.15 per share$2.43 per share
Price / BookN/AN/AN/A3.700.55
Profitability
Net Income$-161,870,000.00$-77,270,000.00$-111,820,000.00$-123,750,000.00$-314,920,000.00
EPS($2.99)($1.58)($4.05)($1.67)($0.41)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/A-122.25%-34.92%
Return on Equity (ROE)-61.14%-32.04%-70.13%-86.32%-14.41%
Return on Assets (ROA)-54.38%-25.27%-60.72%-43.42%-9.99%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.15%N/A0.34%0.15%
Current Ratio8.68%16.81%7.42%3.23%1.30%
Quick Ratio8.68%16.81%7.42%2.77%1.09%
Ownership Information
Institutional Ownership Percentage28.73%94.35%97.51%52.94%26.28%
Insider Ownership Percentage70.63%41.40%59.30%18.80%42.25%
Miscellaneous
Employees111331175756,096
Shares Outstanding55.54 million55.07 million32.06 million81.63 million669.83 million
Next Earnings Date5/7/2020 (Estimated)5/13/2020 (Estimated)4/23/2020 (Estimated)5/14/2020 (Estimated)5/5/2020 (Estimated)
OptionableNot OptionableOptionableNot OptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel